LOPRESSOR

This brand name is authorized in Brazil, France, Tunisia, United States

Active ingredients

The drug LOPRESSOR contains one active pharmaceutical ingredient (API):

1 Metoprolol UNII W5S57Y3A5L - METOPROLOL TARTRATE

Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation. Read about Metoprolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOPRESSOR Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AB02	Metoprolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526509101114317
Country: FR	Base de données publique des médicaments	Identifier(s): 67211976, 69376930
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 12803021
Country: US	FDA, National Drug Code	Identifier(s): 30698-458, 30698-459